Ferrari L, Cattaneo DMIR, Abbate R, Manoni M, Ottoboni M, Luciano A et al (2023) Advances in selenium supplementation: From selenium-enriched yeast to potential selenium-enriched insects, and selenium nanoparticles
The right concentration depends on your current dose, your titration plan, and your comfort with small-volume measurements
Key limitations of the current research include: Small sample sizes in early or pilot human studies Heavy reliance on animal models that may not reflect real-world substance use Limited duration of studies and inconsistent outcome measures The absence of FDA approval for GLP-1 medications in treating substance use disorders Important context to keep in mind: Addiction is influenced by psychological, social, and environmental factors beyond biology Medications alone are not sufficient to address substance use disorders Evidence-based therapies remain the standard of care At this time, GLP-1 medications should not be considered treatments for opioid, nicotine, or stimulant use disorders
The binge eating is required to occur, on average, at least once a week for 3 months (American Psychiatric Association, 2013)